BV
Live price temporarily unavailable.
Brightview Holdings Inc (BV) is a Industrials company in the Russell 2000. Latest news and coverage below.
IPO: June 28, 2018 · $22.00 offering · NYSE · View IPO details →
Recent News (9)
-
BBVA Argentina earnings missed by $0.03, revenue fell short of estimates BBVA Argentina earnings missed by $0.03, revenue fell short of estimates
-
FDA advisers to weigh updated COVID vaccine targeting XFG subvariant The Food and Drug Administration's (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respirato…
-
Two Paths to Growth: Johnson & Johnson vs AbbVie Two Paths to Growth: Johnson & Johnson vs AbbVie
-
What's the Better Dividend Stock Today: AbbVie or Pfizer? What's the Better Dividend Stock Today: AbbVie or Pfizer?
-
Arsenal’s title win should be studied by politicians everywhere – and especially Keir Starmer. Here’s why | Jonathan Freedland
The sensational victory didn’t happen by accident, it took years of dedication and clever planning, something the PM – himself a fan – should note
Obviously, I know that politics and football are diff…
-
The Guardian view on the Mountbatten-Windsor papers: they expose the collapse of Britain’s 'good chap' state | Editorial
New papers matter less for royal gossip than for what they reveal about the UK’s fragile constitutional culture of trust, prestige and informal power
The most shocking revelation in files released on …
-
AbbVie Inc. (ABBV) Positioned for Long-Term Gains with IBD Pipeline Strength AbbVie Inc. (ABBV) Positioned for Long-Term Gains with IBD Pipeline Strength
-
J.P. Morgan Reduces Price Target on Banco Bilbao Vizcaya Argentaria (BBVA), Keeps a Buy Rating J.P. Morgan Reduces Price Target on Banco Bilbao Vizcaya Argentaria (BBVA), Keeps a Buy Rating
-
AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI